Common chemotherapeutic agent reduces resistance to virus therapy in brain tumor patients
Thursday, November 13, 2014 - 04:31
in Health & Medicine
The common chemotherapeutic agent cyclophosphamide can help improve the success of oncolytic virus therapy in patients with malignant gliomas, a common type of brain tumor, researchers have found. Oncolytic virus therapy is an innovative therapeutic approach that uses viruses to target and kill cancer cells. The viruses can be modified to allow them to target specific cancer cells or to deliver therapy-modifying genes.